Tobias Huber

Professor Tobias Huber is a distinguished researcher at the University Medical Center Hamburg-Eppendorf, where he serves in the Department of Medicine III. His work spans multiple research areas including nephrology, immunology, and neuroscience, with a particular focus on kidney diseases and their systemic implications.

Dr. Huber's research focuses primarily on kidney diseases, particularly podocyte biology and glomerular disorders. He has made significant contributions to understanding anti-nephrin autoantibodies, autoimmune kidney diseases, and the intersection of kidney function with neurological conditions. His work often bridges basic science with clinical applications, as evidenced by his extensive publication record spanning from 2015 to present.

Analysis of his recent publications reveals a strong emphasis on molecular mechanisms of kidney disease, with particular attention to autoimmunity, cellular stress responses, and novel diagnostic approaches. His work increasingly explores the connections between kidney function and other organ systems, particularly the nervous system, as seen in his research on kidney-brain axis and neurological sequelae of diseases.

Dr. Huber leads or participates in multiple significant research projects including DEFEAT PANDEMIcs, NephrESA, STOP-FSGS, SFB 1140/1 Teilprojekt A03, and Horizon 2020 funded projects (115974-Beat-DKD, 616891 - DNCure). His work has substantial implications for understanding and treating various forms of kidney disease, including steroid-resistant nephrotic syndrome, lupus nephritis, and Fabry disease.

He is actively involved in mentoring researchers and has likely supervised numerous PhD students and postdoctoral fellows. His laboratory employs diverse methodologies including molecular biology, animal models, human tissue analysis, and multi-omics approaches to investigate kidney disease mechanisms and potential therapeutics.